Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
Takeda Pharmaceutical Company Limited
|
| gptkbp:acquisitionYear |
2008
|
| gptkbp:CEO |
Teresa Bitetti
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
oncology
|
| gptkbp:formerName |
gptkb:Millennium_Pharmaceuticals
|
| gptkbp:foundedYear |
1993
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Takeda Oncology
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:notableProduct |
gptkb:Alunbrig
gptkb:Ninlaro gptkb:Velcade Iclusig |
| gptkbp:parentCompany |
Takeda Pharmaceutical Company Limited
|
| gptkbp:website |
https://www.takedaoncology.com/
|
| gptkbp:bfsParent |
gptkb:Takeda
|
| gptkbp:bfsLayer |
6
|